UVEAL MELANOMA, RECURRENT
Clinical trials for UVEAL MELANOMA, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, RECURRENT trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX in people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink or slow tumors. Participants take…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 23, 2026 20:47 UTC
-
New injection attacks tumors from inside
Disease control Recruiting nowThis early-phase trial tests an experimental drug, ONM-501, injected directly into tumors. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The study aims to find the safest dose and see if combining it with another drug (cemip…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC